Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Gross Profit: 2013-2025

Historic Gross Profit for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to $1.5 million.

  • Ocular Therapeutix's Gross Profit fell 69.99% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 81.45%. This contributed to the annual value of $22.1 million for FY2024, which is 23.69% up from last year.
  • Per Ocular Therapeutix's latest filing, its Gross Profit stood at $1.5 million for Q3 2025, which was up 639.26% from -$270,000 recorded in Q2 2025.
  • Over the past 5 years, Ocular Therapeutix's Gross Profit peaked at $6.4 million during Q2 2024, and registered a low of -$3.5 million during Q1 2025.
  • In the last 3 years, Ocular Therapeutix's Gross Profit had a median value of $4.6 million in 2024 and averaged $3.4 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Gross Profit skyrocketed by 654.30% in 2022, and later slumped by 175.15% in 2025.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Gross Profit stood at $3.2 million in 2021, then rose by 11.70% to $3.5 million in 2022, then spiked by 56.82% to $5.6 million in 2023, then grew by 12.35% to $6.2 million in 2024, then crashed by 69.99% to $1.5 million in 2025.
  • Its Gross Profit was $1.5 million in Q3 2025, compared to -$270,000 in Q2 2025 and -$3.5 million in Q1 2025.